Skip to main content
NIH funding notice RFA-AI-22-022

Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)

Closed on August 3, 2022.

Posted
March 10, 2022
Close date
August 3, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,439,260 in first-year total cost, median $493,296.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 VS-A (J1)]4

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  2. GEORGE WASHINGTON UNIVERSITY1
  3. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  4. UNIVERSITY OF MARYLAND BALTIMORE1
Competing awards under RFA-AI-22-022 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility1R61AI176583-01SHENG, ZIZHANGWU, XUELINGYAMASHITA, MASAHIROYIN, MICHAEL TCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$1,002,428ZAI1
2023Detection Assays for Virion Susceptibility to HIV Broadly Neutralizing Antibodies in Plasma and Culture Fluids1R61AI176561-01DEVICO, ANTHONY LRAY, KRISHANUUNIVERSITY OF MARYLAND BALTIMORE, MD$523,288ZAI1
2023Quantifying bNAb neutralization of the HIV latent reservoir1R61AI176585-01CHEN, BENJAMIN KICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$463,303ZAI1
2023Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening1R61AI176582-01BOSQUE, ALBERTOLYNCH, REBECCA MARIEGEORGE WASHINGTON UNIVERSITY, DC$450,241ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-22-022: Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed) | ScienceDex | ConductScience